Literature DB >> 5221699

Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience.

I M Nilsson, L Andersson, S E Björkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5221699

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN： 0365-463X


× No keyword cloud information.
  11 in total

1.  Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

Authors:  Stephen A Tilles; Larry Borish; Joshua P Cohen
Journal:  Ann Allergy Asthma Immunol       Date:  2012-12-17       Impact factor: 6.347

Review 2.  Antifibrinolytic Therapy and Perioperative Considerations.

Authors:  Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal:  Anesthesiology       Date:  2018-03       Impact factor: 7.892

Review 3.  Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).

Authors:  A Fay; M Abinun
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.

Authors:  D S Fletcher; T Y Lin
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

5.  Epsilon-aminocaproic acid therapy in ulcerative colitis.

Authors:  N A Mowat; A S Douglas; P W Brunt; J A McIntosh; P C King; K Boddy
Journal:  Am J Dig Dis       Date:  1973-11

6.  Possible therapy in hereditary angioneurotic edema (HAE).

Authors:  D Brackertz; F Kueppers
Journal:  Klin Wochenschr       Date:  1973-06-15

Review 7.  C1 inhibitor deficiency: consensus document.

Authors:  M M Gompels; R J Lock; M Abinun; C A Bethune; G Davies; C Grattan; A C Fay; H J Longhurst; L Morrison; A Price; M Price; D Watters
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

8.  Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.

Authors:  H J Gelmers
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

9.  Recombinant and plasma-purified human c1 inhibitor for the treatment of hereditary angioedema.

Authors:  Michael M Frank
Journal:  World Allergy Organ J       Date:  2010-09       Impact factor: 4.084

Review 10.  The Story of Angioedema: from Quincke to Bradykinin.

Authors:  Avner Reshef; Mona Kidon; Iris Leibovich
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 10.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.